Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. November 2015 16:52 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Reports Third Quarter 2015 Results

RAMSEY, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty...
03. November 2015 07:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Announces Data to be Presented at the International Primary Immunodeficiencies Congress in Budapest Hungary

RAMSEY, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
30. September 2015 07:28 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Receives Milestone Payment From Biotest AG for RI-002 BLA Submission to FDA

RAMSEY, N.J., Sept. 30, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
28. September 2015 07:28 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Recognized as One of the 50 Fastest Growing Companies in New Jersey

RAMSEY, N.J., Sept. 28, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
22. September 2015 08:28 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics to Present at the Ladenburg Thalmann 2015 Healthcare Conference

RAMSEY, N.J., Sept. 22, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
21. September 2015 07:28 ET | Quelle: ADMA Biologics, Inc.

FDA Accepts ADMA Biologics License Application for RI-002

RAMSEY, N.J., Sept. 21, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
17. September 2015 07:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Receives FDA Approval for Second Plasma Collection Center

RAMSEY, N.J., Sept. 17, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
02. September 2015 08:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

RAMSEY, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...
31. August 2015 16:34 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Receives Patent Issuance Pertaining to the Treatment of Immunodeficiency

RAMSEY, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company, announced that the U.S. Patent and Trademark Office (USPTO) has issued...
11. August 2015 16:38 ET | Quelle: ADMA Biologics, Inc.

ADMA Biologics Reports Second Quarter 2015 Results

RAMSEY, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty...

Vorherige Seite